135 related articles for article (PubMed ID: 11225734)
1. Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications.
Ripple MO; Hagopian K; Oberley TD; Schatten H; Weindruch R
Antioxid Redox Signal; 1999; 1(1):71-81. PubMed ID: 11225734
[TBL] [Abstract][Full Text] [Related]
2. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
Ripple MO; Henry WF; Rago RP; Wilding G
J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405
[TBL] [Abstract][Full Text] [Related]
3. Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies.
Lin H; Lu JP; Laflamme P; Qiao S; Shayegan B; Bryskin I; Monardo L; Wilson BC; Singh G; Pinthus JH
Int J Oncol; 2010 Oct; 37(4):761-6. PubMed ID: 20811696
[TBL] [Abstract][Full Text] [Related]
4. Androgen and taxol cause cell type-specific alterations of centrosome and DNA organization in androgen-responsive LNCaP and androgen-independent DU145 prostate cancer cells.
Schatten H; Ripple M; Balczon R; Weindruch R; Chakrabarti A; Taylor M; Hueser CN
J Cell Biochem; 2000 Jan; 76(3):463-77. PubMed ID: 10649443
[TBL] [Abstract][Full Text] [Related]
5. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP.
Joly-Pharaboz MO; Soave MC; Nicolas B; Mebarki F; Renaud M; Foury O; Morel Y; Andre JG
J Steroid Biochem Mol Biol; 1995 Oct; 55(1):67-76. PubMed ID: 7577722
[TBL] [Abstract][Full Text] [Related]
6. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer.
Liao X; Thrasher JB; Pelling J; Holzbeierlein J; Sang QX; Li B
Endocrinology; 2003 May; 144(5):1656-63. PubMed ID: 12697668
[TBL] [Abstract][Full Text] [Related]
7. Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells.
Ripple MO; Henry WF; Schwarze SR; Wilding G; Weindruch R
J Natl Cancer Inst; 1999 Jul; 91(14):1227-32. PubMed ID: 10413424
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction.
Berridge MV; Tan AS
Arch Biochem Biophys; 1993 Jun; 303(2):474-82. PubMed ID: 8390225
[TBL] [Abstract][Full Text] [Related]
9. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.
Swinnen JV; Van Veldhoven PP; Esquenet M; Heyns W; Verhoeven G
Endocrinology; 1996 Oct; 137(10):4468-74. PubMed ID: 8828509
[TBL] [Abstract][Full Text] [Related]
10. Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells.
Qi H; Labrie Y; Grenier J; Fournier A; Fillion C; Labrie C
Mol Cell Endocrinol; 2001 Sep; 182(2):181-92. PubMed ID: 11514053
[TBL] [Abstract][Full Text] [Related]
11. Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.
Romijn JC; Verkoelen CF; Schroeder FH
Prostate; 1988; 12(1):99-110. PubMed ID: 3126493
[TBL] [Abstract][Full Text] [Related]
12. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E succinate protects hepatocytes against the toxic effect of reactive oxygen species generated at mitochondrial complexes I and III by alkylating agents.
Zhang JG; Nicholls-Grzemski FA; Tirmenstein MA; Fariss MW
Chem Biol Interact; 2001 Dec; 138(3):267-84. PubMed ID: 11714483
[TBL] [Abstract][Full Text] [Related]
14. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
Kimura K; Markowski M; Bowen C; Gelmann EP
Cancer Res; 2001 Jul; 61(14):5611-8. PubMed ID: 11454715
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
Bauer JA; Thompson TA; Church DR; Ariazi EA; Wilding G
Prostate; 2003 May; 55(3):159-67. PubMed ID: 12692781
[TBL] [Abstract][Full Text] [Related]
16. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
Guillemette C; Hum DW; Bélanger A
Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial electron transport inhibitors cause lipid peroxidation-dependent and -independent cell death: protective role of antioxidants.
Zhang JG; Tirmenstein MA; Nicholls-Grzemski FA; Fariss MW
Arch Biochem Biophys; 2001 Sep; 393(1):87-96. PubMed ID: 11516165
[TBL] [Abstract][Full Text] [Related]
18. Alteration in gamma-glutamyl transpeptidase activity and messenger RNA of human prostate carcinoma cells by androgen.
Ripple MO; Pickhardt PA; Wilding G
Cancer Res; 1997 Jun; 57(12):2428-33. PubMed ID: 9192821
[TBL] [Abstract][Full Text] [Related]
19. Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.
Blok LJ; Chang GT; Steenbeek-Slotboom M; van Weerden WM; Swarts HG; De Pont JJ; van Steenbrugge GJ; Brinkmann AO
Br J Cancer; 1999 Sep; 81(1):28-36. PubMed ID: 10487609
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
